BEAM
Beam Therapeutics Inc.
Overview
Beam Therapeutics Inc is a Healthcare company operating in Biotechnology with a $3.66B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
2 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from SEC 10-K filing, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $1.00—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $1.00 | — | — | — | — | EODHD |
Source: EODHD. BEAM reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks BEAM's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2025 | $3.42 | $2.55 | +34.1% | -2.2% | -2.7% |
| Q4 FY2025 | $3.61 | $2.79 | +29.5% | +6.5% | +4.9% |
| Q3 FY2025 | $3.90 | $2.73 | +42.7% | -1.2% | -0.9% |
| Q2 FY2025 | $3.51 | $2.71 | +29.4% | +2.3% | +1.8% |
| Q1 FY2024 | $3.63 | $2.63 | +38.0% | +1.5% | +0.2% |
| Q4 FY2024 | $3.99 | $2.77 | +44.1% | +7.6% | +7.6% |
| Q3 FY2024 | $3.59 | $2.73 | +31.5% | +4.7% | +3.7% |
| Q2 FY2024 | $3.59 | $2.75 | +30.5% | +7.9% | +10.7% |
| Q1 FY2023 | $3.73 | $2.82 | +32.1% | +3.9% | +3.4% |
| Q4 FY2023 | $3.82 | $2.92 | +30.7% | +5.4% | +7.6% |
Guidance change history
Sample- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
- Q1 FY2024Raised2024-04-15
- Q4 FY2024Raised2024-13-15
- Q3 FY2024Raised2024-10-15
- Q2 FY2024Raised2024-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- John M EvansCEO8 mo2 callsCurrentSample
CEO since 2025 • 1/2 beats (50%) • last guidance cut Q3 FY2025
- Sravan Kumar EmanyCFO6 mono recorded callsCurrentSample
CFO since 2025 • 1/2 beats (50%) • last guidance cut Q1 FY2025
- Giuseppe CiaramellaPresident5 mo2 callsCurrentSample
PRESIDENT since 2026 • 2/2 beats (100%) • guidance suspended Q3 FY2025
- Christine BellonChief Legal Officer8 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 1/2 beats (50%) • last call held guidance Q1 FY2025
- Amy SimonChief Medical Officer11 mo2 callsCurrentSample
OTHER_C_SUITE since 2025 • 1/2 beats (50%) • last guidance raise Q2 FY2025
- Bethany J CavanaghSVP, Finance and Treasurer8 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 1/2 beats (50%) • last guidance cut Q1 FY2025
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BEAM.
$ curl https://api.spokenalpha.com/v1/companies/BEAMFAQ
Frequently asked about BEAM
Where can I find Beam Therapeutics Inc.'s (BEAM) earnings call transcripts?
Spoken Alpha indexes BEAM's earnings call transcripts at https://spokenalpha.com/companies/BEAM. Each call links to attributed speakers and parsed analyst Q&A. Beam Therapeutics Inc.'s own investor relations page is at https://investors.beamtx.com/.
When was Beam Therapeutics Inc.'s most recent earnings call?
Beam Therapeutics Inc. (BEAM) held its most recent earnings call on 2026-02-24, covering fiscal Q4 2025.
What sector is BEAM in?
Beam Therapeutics Inc. (BEAM) operates in the Healthcare sector (Biotechnology industry).